Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aluminum in tissues.

F L Van de Vyver, M E De Broe

    Clinical Nephrology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Aluminum accumulation in patients, especially those with chronic renal failure, presents a heterogeneous distribution, differing from normal patterns. Treatment with desferrioxamine effectively reduces tissue aluminum and associated pathologies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning.

    Journal of endocrinological investigation·2019
    Same author

    Use of laser microprobe mass analysis (LAMMA) for localizing multiple elements in soft and hard tissues.

    Biological trace element research·2013
    Same author

    Effects of foetal calf serum on cell viability, cytotoxicity and detoxification in the two kidney-derived cell lines LLC-PK1 and MDCK.

    Toxicology in vitro : an international journal published in association with BIBRA·2010
    Same author

    Osteodystrophy in chronic renal failure patients.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
    Same author

    Endochondral bone formation is involved in media calcification in rats and in men.

    Kidney international·2007
    Same author

    Uremia-related vascular calcification: more than apatite deposition.

    Kidney international·2006
    Same journal

    Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study.

    Clinical nephrology·2026
    Same journal

    Analysis of end-stage renal disease mediated by cuproptosis-related genes.

    Clinical nephrology·2026
    Same journal

    The relationship between red cell distribution width and platelet ratio in acute kidney injury among ventilator-associated pneumonia patients: A MIMIC-IV database study.

    Clinical nephrology·2026
    Same journal

    Arterial stiffness and choroidal vascularity index in autosomal dominant polycystic kidney disease with preserved kidney function.

    Clinical nephrology·2026
    Same journal

    Antibody-drug conjugate therapy in a renal transplant patient with bladder cancer: A case report.

    Clinical nephrology·2026
    Same journal

    Epigenetic age enhances eGFR-based prediction of all-cause mortality: A cross-cohort validation of a novel risk model.

    Clinical nephrology·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Toxicology
    • Neurology

    Background:

    • Aluminum accumulation is observed in patients with chronic renal failure.
    • Aluminum toxicity is linked to dialysis encephalopathy, osteomalacia, and anemia.
    • The distribution of aluminum in the body differs between normal individuals and those with aluminum overload.

    Purpose of the Study:

    • To investigate the distribution patterns of aluminum in patients with chronic renal failure and aluminum overload.
    • To explore the relationship between aluminum distribution and organ dysfunction.
    • To assess the efficacy of desferrioxamine in reducing tissue aluminum levels and associated pathology.

    Main Methods:

    • Analysis of aluminum distribution in various tissues, including the brain, in patients with severe renal failure and aluminum overload.

    Related Experiment Videos

  • Comparison of aluminum distribution in affected patients versus normal individuals.
  • Evaluation of the effects of desferrioxamine administration on tissue aluminum levels and clinical pathology.

    • Main Results:

    • Aluminum exhibits a heterogeneous distribution throughout the body in patients with aluminum accumulation, distinct from normal patterns.
    • In severe renal failure and aluminum overload, aluminum distribution in the brain is notably heterogeneous.
    • Desferrioxamine administration led to decreased tissue aluminum levels and regression of aluminum-associated pathology.

    Conclusions:

    • Aluminum accumulation in chronic renal failure patients shows a distinct, heterogeneous distribution.
    • Desferrioxamine is effective in mitigating aluminum toxicity by reducing tissue aluminum burden and improving associated conditions.